Heatstroke Comorbid with SARS-CoV-2 Infection: A Case Report and Literature Review

Overview

Journal Int Med Case Rep J

Publisher Dove Medical Press

Specialty General Medicine

Date 2024 Jun 4

PMID 38831931

Authors

Xiao-Xiao Ni

Zhe-Ying Liu

Yan-Yan Zeng

Zhi-Feng Liu

Affiliations

Soon will be listed here.

Abstract

Background: Hyperthermia and multiple organ dysfunction syndrome (MODS) are the main characteristics of heatstroke and COVID-19. Differentiating between these illnesses is crucial during a summer COVID-19 pandemic, but cases of heatstroke comorbid with COVID-19 are rarely reported.

Case Description: We report the first case of heatstroke comorbid with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in a 52-year-old male. After receiving intravenous antibiotics, organ protection measures, and treatment for coagulation disorders, his fever and coma resolved. However, he developed dyspnea and cerebral hemorrhage after several days. This patient experienced a multi-pathogen pulmonary infection and an intractable coagulopathy that ultimately resulted in MODS and death.

Conclusion: The combination of heatstroke and SARS-CoV-2 infection exacerbated inflammation, immune abnormalities, and coagulation disorders. The interaction between inflammation and coagulation disturbances contributed to the underlying mechanism in this case, highlighting the importance of early anti-infection, treatment for coagulopathy, immune regulation, and organ protection as crucial interventions.

References

Lu K, Wang J, Lin S, Chu P, Lin Y . Role of circulating cytokines and chemokines in exertional heatstroke. Crit Care Med. 2004; 32(2):399-403. DOI: 10.1097/01.CCM.0000108884.74110.D9. View

Zhong L, Wu M, Ji J, Wang C, Liu Z . Association Between Platelet Levels on Admission and 90-day Mortality in Patients With Exertional Heatstroke, a 10 Years Cohort Study. Front Med (Lausanne). 2021; 8:716058. PMC: 8632220. DOI: 10.3389/fmed.2021.716058. View

Alexaki V, Henneicke H . The Role of Glucocorticoids in the Management of COVID-19. Horm Metab Res. 2020; 53(1):9-15. PMC: 7781662. DOI: 10.1055/a-1300-2550. View

Wang F, Zhang Y, Li J, Xia H, Zhang D, Yao S . The pathogenesis and therapeutic strategies of heat stroke-induced liver injury. Crit Care. 2022; 26(1):391. PMC: 9758799. DOI: 10.1186/s13054-022-04273-w. View

Hifumi T, Kondo Y, Shimizu K, Miyake Y . Heat stroke. J Intensive Care. 2018; 6:30. PMC: 5964884. DOI: 10.1186/s40560-018-0298-4. View

Iba T, Connors J, Levi M, Levy J . Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management. EClinicalMedicine. 2022; 44:101276. PMC: 8792067. DOI: 10.1016/j.eclinm.2022.101276. View

Asmara I . Diagnosis and Management of Heatstroke. Acta Med Indones. 2020; 52(1):90-97. View

Robba C, Battaglini D, Pelosi P, Rocco P . Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020; 14(9):865-868. PMC: 7441756. DOI: 10.1080/17476348.2020.1778470. View

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla A . COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020; 13(12):1833-1839. PMC: 7402107. DOI: 10.1016/j.jiph.2020.07.014. View

10.

Asakura H, Ogawa H . COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2020; 113(1):45-57. PMC: 7648664. DOI: 10.1007/s12185-020-03029-y. View

11.

Zheng X, Guan W, Zhong N . Clinical characteristics of COVID-19 in developing countries of western pacific: Low case-fatality rate unraveled. Lancet Reg Health West Pac. 2021; 6:100073. PMC: 7723517. DOI: 10.1016/j.lanwpc.2020.100073. View

12.

Lazzaroni M, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A . Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2020; 46:100745. PMC: 7444609. DOI: 10.1016/j.blre.2020.100745. View

13.

Ali F, Abd El-Aziz M, Ali M, Ghogar O, Bakr A . COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells. World J Gastroenterol. 2023; 29(3):425-449. PMC: 9850933. DOI: 10.3748/wjg.v29.i3.425. View

14.

Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S . AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol. 2020; 32(1):151-160. PMC: 7894657. DOI: 10.1681/ASN.2020050615. View

15.

Kim Y, Shin E . Type I and III interferon responses in SARS-CoV-2 infection. Exp Mol Med. 2021; 53(5):750-760. PMC: 8099704. DOI: 10.1038/s12276-021-00592-0. View

16.

Pasero D, Terragni P . Should we treat fever in critically ill COVID-19 patients?. Minerva Anestesiol. 2021; 87(11):1168-1170. DOI: 10.23736/S0375-9393.21.16199-1. View

17.

Ren X, Wen W, Fan X, Hou W, Su B, Cai P . COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021; 184(7):1895-1913.e19. PMC: 7857060. DOI: 10.1016/j.cell.2021.01.053. View

18.

Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone F . Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. 2020; 95(14):e2016-e2027. DOI: 10.1212/WNL.0000000000010116. View

19.

Goto H, Kinoshita M, Oshima N . Heatstroke-induced acute kidney injury and the innate immune system. Front Med (Lausanne). 2023; 10:1250457. PMC: 10442538. DOI: 10.3389/fmed.2023.1250457. View

20.

Ahmadian E, Hosseiniyan Khatibi S, Soofiyani S, Abediazar S, Shoja M, Ardalan M . Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2020; 31(3):e2176. PMC: 7646060. DOI: 10.1002/rmv.2176. View